These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20547172)

  • 1. Analysis of camelid IgG for antivenom development: Immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment.
    Cook DA; Samarasekara CL; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(4):596-603. PubMed ID: 20547172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralisation of venom-induced haemorrhage by IgG from camels and llamas immunised with viper venom and also by endogenous, non-IgG components in camelid sera.
    Harrison RA; Hasson SS; Harmsen M; Laing GD; Conrath K; Theakston RD
    Toxicon; 2006 Mar; 47(3):364-8. PubMed ID: 16359717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of camelid antibodies for antivenom development: Neutralisation of venom-induced pathology.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):373-80. PubMed ID: 20412814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production and preclinical assessment of camelid immunoglobulins against Echis sochureki venom from desert of Rajasthan, India.
    Tanwar PD; Ghorui SK; Kochar SK; Singh R; Patil NV
    Toxicon; 2017 Aug; 134():1-5. PubMed ID: 28528176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):363-72. PubMed ID: 20362604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-clinical assays predict pan-African Echis viper efficacy for a species-specific antivenom.
    Casewell NR; Cook DA; Wagstaff SC; Nasidi A; Durfa N; Wüster W; Harrison RA
    PLoS Negl Trop Dis; 2010 Oct; 4(10):e851. PubMed ID: 21049058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics and multiepitope DNA immunization to design rational snake antivenom.
    Wagstaff SC; Laing GD; Theakston RD; Papaspyridis C; Harrison RA
    PLoS Med; 2006 Jun; 3(6):e184. PubMed ID: 16737347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa.
    Segura A; Villalta M; Herrera M; León G; Harrison R; Durfa N; Nasidi A; Calvete JJ; Theakston RD; Warrell DA; Gutiérrez JM
    Toxicon; 2010; 55(2-3):369-74. PubMed ID: 19699756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa.
    Habib AG; Warrell DA
    Toxicon; 2013 Jul; 69():82-9. PubMed ID: 23339853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
    Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of quality, safety, and pre-clinical toxicity of an equine polyvalent anti-snake venom (Pan Africa): Determination of immunological cross-reactivity of antivenom against venom samples of Elapidae and Viperidae snakes of Africa.
    Patra A; Kalita B; Mukherjee AK
    Toxicon; 2018 Oct; 153():120-127. PubMed ID: 30189243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactivity and cross-immunomodulation between venoms of the snakes Bothrops asper, Crotalus simus and Lachesis stenophrys, and its effect in the production of polyspecific antivenom for Central America.
    Arroyo C; Solano S; Segura Á; Herrera M; Estrada R; Villalta M; Vargas M; Gutiérrez JM; León G
    Toxicon; 2017 Nov; 138():43-48. PubMed ID: 28803057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom.
    Meyer WP; Habib AG; Onayade AA; Yakubu A; Smith DC; Nasidi A; Daudu IJ; Warrell DA; Theakston RD
    Am J Trop Med Hyg; 1997 Mar; 56(3):291-300. PubMed ID: 9129531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of whole IgG equine antivenom: comparison between normal and envenomed rabbits.
    Quesada L; Sevcik C; Lomonte B; Rojas E; Gutiérrez JM
    Toxicon; 2006 Sep; 48(3):255-63. PubMed ID: 16863656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Camelid antivenom development and potential in vivo neutralization of Hottentotta saulcyi scorpion venom.
    Darvish M; Ebrahimi SA; Shahbazzadeh D; Bagheri KP; Behdani M; Shokrgozar MA
    Toxicon; 2016 Apr; 113():70-5. PubMed ID: 26809016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding anti-venom strategies: Camelid polyclonal antibodies with high capacity to recognize snake venom.
    Campos Farias BJ; Makoto Kayano A; Barros Luiz M; Maciel DE Lima A; Suelen da Silva Morais M; Moreira Mendes L; Mota Santana H; Reis Prado ND; Andrade Roberto S; Martins Soares A; Pavan Zuliani J; Pereira SDS; Celedonio Fernandes CF
    Toxicon; 2024 Aug; 247():107837. PubMed ID: 38945216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of high titre antibody response against Russell's viper venom in mice immunized with ethanolic extract of fruits of Piper longum L. (Piperaceae) and piperine.
    Shenoy PA; Nipate SS; Sonpetkar JM; Salvi NC; Waghmare AB; Chaudhari PD
    Phytomedicine; 2014 Jan; 21(2):159-63. PubMed ID: 24060214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
    O'Leary MA; Isbister GK
    Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Third Generation Antivenomics: Pushing the Limits of the In Vitro Preclinical Assessment of Antivenoms.
    Pla D; Rodríguez Y; Calvete JJ
    Toxins (Basel); 2017 May; 9(5):. PubMed ID: 28489039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.